Erasca Inc

NASDAQ:ERAS 1:00:00 PM EDT

1.44

-0.01 (-0.69%)

4:04:34 PM EDT: $1.37 -0.07 (-4.86%)

Erasca Inc Stock, NASDAQ:ERAS

3115 Merryfield Row, Suite 300, San Diego, California 92121

United States of America

Phone: +1.858.465.6511

Number of Employees: 126

http://www.erasca.com

Description

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.